342 related articles for article (PubMed ID: 22193347)
1. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
[TBL] [Abstract][Full Text] [Related]
2. Rate control with ivabradine: angina pectoris and beyond.
Parakh N; Bhargava B
Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
Borer JS; Le Heuzey JY
Am J Ther; 2008; 15(5):461-73. PubMed ID: 18806523
[TBL] [Abstract][Full Text] [Related]
4. I(f) inhibition in cardiovascular diseases.
Thollon C; Vilaine JP
Adv Pharmacol; 2010; 59():53-92. PubMed ID: 20933199
[TBL] [Abstract][Full Text] [Related]
5. Ivabradine: beyond heart rate control.
Riccioni G; Vitulano N; D'Orazio N
Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
[TBL] [Abstract][Full Text] [Related]
6. [Ivabradine -- a novel approach for heart rate lowering].
Er F; Hoppe UC
Dtsch Med Wochenschr; 2005 Jun; 130(24):1501-2. PubMed ID: 15942839
[No Abstract] [Full Text] [Related]
7. Ivabradine: pharmacodynamic aspects of its clinical use.
Stieber J
Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
[TBL] [Abstract][Full Text] [Related]
8. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
Prasad UK; Gray D; Purcell H
Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
[TBL] [Abstract][Full Text] [Related]
9. Focus on ivabradine: a new heart rate-controlling drug.
Riccioni G
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
[TBL] [Abstract][Full Text] [Related]
10. The funny current: cellular basis for the control of heart rate.
DiFrancesco D; Borer JS
Drugs; 2007; 67 Suppl 2():15-24. PubMed ID: 17999560
[TBL] [Abstract][Full Text] [Related]
11. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
Ferrari R; Ceconi C
Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):959-73. PubMed ID: 21878041
[TBL] [Abstract][Full Text] [Related]
12. Ivabradine: recent and potential applications in clinical practice.
Riccioni G
Expert Opin Pharmacother; 2011 Feb; 12(3):443-50. PubMed ID: 21254949
[TBL] [Abstract][Full Text] [Related]
13. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
Sulfi S; Timmis AD
Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
[TBL] [Abstract][Full Text] [Related]
14. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
15. Novel If current inhibitor ivabradine: safety considerations.
Savelieva I; Camm AJ
Adv Cardiol; 2006; 43():79-96. PubMed ID: 16936474
[TBL] [Abstract][Full Text] [Related]
16. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
Rosano GM; Vitale C; Volterrani M
Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895
[TBL] [Abstract][Full Text] [Related]
17. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
Canet E; Lerebours G; Vilaine JP
Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
[TBL] [Abstract][Full Text] [Related]
18. Ivabradine: from molecular basis to clinical effectiveness.
Riccioni G
Adv Ther; 2010 Mar; 27(3):160-7. PubMed ID: 20419486
[TBL] [Abstract][Full Text] [Related]
19. [A New Insight on Anti-Ischemic Action of Ivabradine in Patients With Stable Angina].
Kobalava ZD; Shavarov AA; Kiyakbaev GK
Kardiologiia; 2017 Mar; 57(3):68-74. PubMed ID: 28762939
[TBL] [Abstract][Full Text] [Related]
20. Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis.
Busseuil D; Shi Y; Mecteau M; Brand G; Gillis MA; Thorin E; Asselin C; Roméo P; Leung TK; Latour JG; Des Rosiers C; Bouly M; Rhéaume E; Tardif JC
Cardiology; 2010; 117(3):234-42. PubMed ID: 21212673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
